Narrow search
Showing 1 - 10 of 9,393
Cover Image
Cost-effectiveness of posaconazole tablets versus fluconazole as prophylaxis for invasive fungal diseases in patients with graft-versus-host disease after allogeneic hematopoietic...
Grau, Santiago; Cámara, Rafael; Jurado, Manuel; Sanz, Jaime - In: The European journal of health economics : HEPAC ; … 19 (2018) 4, pp. 627-636
Persistent link: https://www.econbiz.de/10011947142
Cover Image
Palivizumab in the prevention of severe respiratory syncytial virus infection in children with congenital heart disease : a novel cost-utility modeling study reflecting evidence-ba...
Schmidt, Ralph; Majer, Istvan; Román, Natalia García; … - In: Health economics review 7 (2017) 47, pp. 1-8
children with congenital heart disease (CHD). This study estimated the cost-effectiveness of palivizumab prophylaxis versus … later years, was constructed to evaluate the benefits and costs associated with palivizumab versus no prophylaxis among … Spanish guidelines, costs and effects were discounted at 3%. Results: Over a lifetime horizon, palivizumab prophylaxis yielded …
Persistent link: https://www.econbiz.de/10011764192
Cover Image
Thyroid disease
Brook, Robert Henry; Lohr, Kathleen N.; Goldberg, George A. - 1982
Persistent link: https://www.econbiz.de/10000341752
Cover Image
Peptic ulcer disease
Zielske, John V. (contributor) - 1982
Persistent link: https://www.econbiz.de/10000341759
Cover Image
Preventable death and disease
Kisch, Arnold I. (contributor);  … - 1977
Persistent link: https://www.econbiz.de/10000093542
Cover Image
Vetch to Zymotic Diseases
1911 - 11./12. ed
Persistent link: https://www.econbiz.de/10000103108
Cover Image
The prevention of lifestyle-related chronic diseases : an economic framework
Sassi, Franco (contributor); Hurst, Jeremy (contributor) - 2008
Persistent link: https://www.econbiz.de/10003715241
Cover Image
Gesundheitsökonomische Szenarien zur Prävention
Martin, Karl; Henke, Klaus-Dirk - 2008 - 1. Aufl.
Investitionen in die Gesundheit und Bildung könnten die negativen Folgen des demographischen Wandels und der Globalisierung durch eine Erhöhung der Altersgrenze bis 2050 auf 70 Jahre mildern. Damit soll keine bestimmte gesetzliche Altersgrenze begründet oder gar fixiert werden. Eine Erhöhung...
Persistent link: https://www.econbiz.de/10003731516
Cover Image
ECDC strategic multi-annual programme 2007 - 2013 : public health activities, disease-specific programmes and multilateral partnerships ; [... its tenth and twelfth meetings in Vie...
2008
Recoge: INtroduction - The communicable disease challenges to the European Union 2007-20013 - ECDC's role in 2007 …
Persistent link: https://www.econbiz.de/10003760224